Mitochondrial aminoacyl-tRNA synthetases in human disease

Molecular Genetics and Metabolism

Volumn 108, Issue 4, 2013, Pages 206-211

  Konovalova, Svetlana ^a   Tyynismaa, Henna ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aminoacyl tRNA synthetases; Mitochondria; Mitochondrial disease

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; MITOCHONDRIAL DNA; MITOCHONDRIAL ENZYME;

AMINOACYLATION; ANEMIA; CARDIOMYOPATHY; CEREBELLAR ATAXIA; GENE DUPLICATION; GENE MUTATION; GENETIC LINKAGE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; KIDNEY FAILURE; KIDNEY TUBULE DISORDER; LEUKOENCEPHALOPATHY; LOSS OF FUNCTION MUTATION; MISSENSE MUTATION; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE K RAS; PERCEPTION DEAFNESS; PERIPHERAL NEUROPATHY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKIN FIBROBLAST; SPASTICITY; WHITE MATTER;

AMINO ACYL-TRNA SYNTHETASES; BRAIN DISEASES, METABOLIC; DNA, MITOCHONDRIAL; FEMALE; HEREDITARY SENSORY AND MOTOR NEUROPATHY; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUSCULAR DISEASES; RNA, TRANSFER;

EID: 84875256031     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.01.010     Document Type: Review

References (38)

1. Christian B.E., Spremulli L.L. Mechanism of protein biosynthesis in mammalian mitochondria. Biochim. Biophys. Acta 2012, 1819:1035-1054.
2. Watanabe K. Unique features of animal mitochondrial translation systems. The non-universal genetic code, unusual features of the translational apparatus and their relevance to human mitochondrial diseases. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010, 86:11-39.
3. Ibba M., Soll D. Aminoacyl-tRNA synthesis. Annu. Rev. Biochem. 2000, 69:617-650.
4. Ling J., Reynolds N., Ibba M. Aminoacyl-tRNA synthesis and translational quality control. Annu. Rev. Microbiol. 2009, 63:61-78.
5. Nagao A., Suzuki T., Katoh T., Sakaguchi Y. Biogenesis of glutaminyl-mt tRNAGln in human mitochondria. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:16209-16214.
6. Nunnari J., Suomalainen A. Mitochondria: in sickness and in health. Cell 2012, 148:1145-1159.
7. Scheper G.C., van der Klok T., van Andel R.J., van Berkel C.G., Sissler M., Smet J., Muravina T.I., Serkov S.V., Uziel G., Bugiani M., Schiffmann R., Krageloh-Mann I., Smeitink J.A., Florentz C., Van Coster R., Pronk J.C., van der Knaap M.S. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat. Genet. 2007, 39:534-539.
8. Isohanni P., Linnankivi T., Buzkova J., Lonnqvist T., Pihko H., Valanne L., Tienari P.J., Elovaara I., Pirttila T., Reunanen M., Koivisto K., Marjavaara S., Suomalainen A. DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis. J. Med. Genet. 2010, 47:66-70.
9. van Berge L., Dooves S., van Berkel C.G., Polder E., van der Knaap M.S., Scheper G.C. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell type-dependent splicing of mtAspRS mRNA. Biochem. J. 2012, 441:955-962.
10. Miyake N., Yamashita S., Kurosawa K., Miyatake S., Tsurusaki Y., Doi H., Saitsu H., Matsumoto N. A novel homozygous mutation of DARS2 may cause a severe LBSL variant. Clin. Genet. 2011, 80:293-296.
11. S. Yamashita, N. Miyake, N. Matsumoto, H. Osaka, M. Iai, N. Aida, Y. Tanaka, Neuropathology of leukoencephalopathy with brainstem and spinal cord involvement and high lactate caused by a homozygous mutation of DARS2, Brain Dev. (in press), http://dx.doi.org/10.1016/j.braindev.2012.05.007.
12. Synofzik M., Schicks J., Lindig T., Biskup S., Schmidt T., Hansel J., Lehmann-Horn F., Schols L. Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation. J. Med. Genet. 2011, 48:713-715.
13. Edvardson S., Shaag A., Kolesnikova O., Gomori J.M., Tarassov I., Einbinder T., Saada A., Elpeleg O. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am. J. Hum. Genet. 2007, 81:857-862.
14. Cassandrini D., Cilio M.R., Bianchi M., Doimo M., Balestri M., Tessa A., Rizza T., Sartori G., Meschini M.C., Nesti C., Tozzi G., Petruzzella V., Piemonte F., Bisceglia L., Bruno C., Dionisi-Vici C., D'Amico A., Fattori F., Carrozzo R., Salviati L., Santorelli F.M., Bertini E. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients. J. Inherit. Metab. Dis. 2013, 36:45-53.
15. Steenweg M.E., Ghezzi D., Haack T., Abbink T.E., Martinelli D., van Berkel C.G., Bley A., Diogo L., Grillo E., Te Water Naude J., Strom T.M., Bertini E., Prokisch H., van der Knaap M.S., Zeviani M. Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. Brain 2012, 135:1387-1394.
16. B. Talim, A. Pyle, H. Griffin, H. Topaloglu, A. Tokatli, M.J. Keogh, M. Santibanez-Koref, P.F. Chinnery, R.Horvath,Multisystemfatal infantile disease caused by a novel homozygous EARS2 mutation, Brain (in press) (). http://brain.oxfordjournals.org/content/early/2012/09/24/brain.aws197.long.
17. Bayat V., Thiffault I., Jaiswal M., Tetreault M., Donti T., Sasarman F., Bernard G., Demers-Lamarche J., Dicaire M.J., Mathieu J., Vanasse M., Bouchard J.P., Rioux M.F., Lourenco C.M., Li Z., Haueter C., Shoubridge E.A., Graham B.H., Brais B., Bellen H.J. Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS Biol. 2012, 10:e1001288.
18. Thiffault I., Rioux M.F., Tetreault M., Jarry J., Loiselle L., Poirier J., Gros-Louis F., Mathieu J., Vanasse M., Rouleau G.A., Bouchard J.P., Lesage J., Brais B. A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. Brain 2006, 129:2332-2340.
19. Elo J.M., Yadavalli S.S., Euro L., Isohanni P., Gotz A., Carroll C.J., Valanne L., Alkuraya F.S., Uusimaa J., Paetau A., Caruso E.M., Pihko H., Ibba M., Tyynismaa H., Suomalainen A. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum. Mol. Genet. 2012, 21:4521-4529.
20. Riley L.G., Cooper S., Hickey P., Rudinger-Thirion J., McKenzie M., Compton A., Lim S.C., Thorburn D., Ryan M.T., Giege R., Bahlo M., Christodoulou J. Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia-MLASA syndrome. Am. J. Hum. Genet. 2010, 87:52-59.
21. Sasarman F., Nishimura T., Thiffault I., Shoubridge E.A. A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia. Hum. Mutat. 2012, 33:1201-1206.
22. Bykhovskaya Y., Casas K., Mengesha E., Inbal A., Fischel-Ghodsian N. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 2004, 74:1303-1308.
23. Belostotsky R., Ben-Shalom E., Rinat C., Becker-Cohen R., Feinstein S., Zeligson S., Segel R., Elpeleg O., Nassar S., Frishberg Y. Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am. J. Hum. Genet. 2011, 88:193-200.
24. Chimnaronk S., Gravers Jeppesen M., Suzuki T., Nyborg J., Watanabe K. Dual-mode recognition of noncanonical tRNAs(Ser) by seryl-tRNA synthetase in mammalian mitochondria. EMBO J. 2005, 24:3369-3379.
25. Götz A., Tyynismaa H., Euro L., Ellonen P., Hyotylainen T., Ojala T., Hamalainen R.H., Tommiska J., Raivio T., Oresic M., Karikoski R., Tammela O., Simola K.O., Paetau A., Tyni T., Suomalainen A. Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am. J. Hum. Genet. 2011, 88:635-642.
26. Calvo S.E., Compton A.G., Hershman S.G., Lim S.C., Lieber D.S., Tucker E.J., Laskowski A., Garone C., Liu S., Jaffe D.B., Christodoulou J., Fletcher J.M., Bruno D.L., Goldblatt J., Dimauro S., Thorburn D.R., Mootha V.K. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci. Transl. Med. 2012, 4:118ra10.
27. Guo M., Chong Y.E., Shapiro R., Beebe K., Yang X.L., Schimmel P. Paradox of mistranslation of serine for alanine caused by AlaRS recognition dilemma. Nature 2009, 462:808-812.
28. Pierce S.B., Chisholm K.M., Lynch E.D., Lee M.K., Walsh T., Opitz J.M., Li W., Klevit R.E., King M.C. Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6543-6548.
29. Antonellis A., Ellsworth R.E., Sambuughin N., Puls I., Abel A., Lee-Lin S.Q., Jordanova A., Kremensky I., Christodoulou K., Middleton L.T., Sivakumar K., Ionasescu V., Funalot B., Vance J.M., Goldfarb L.G., Fischbeck K.H., Green E.D. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 2003, 72:1293-1299.
30. McLaughlin H.M., Sakaguchi R., Liu C., Igarashi T., Pehlivan D., Chu K., Iyer R., Cruz P., Cherukuri P.F., Hansen N.F., Mullikin J.C., Biesecker L.G., Wilson T.E., Ionasescu V., Nicholson G., Searby C., Talbot K., Vance J.M., Zuchner S., Szigeti K., Lupski J.R., Hou Y.M., Green E.D., Antonellis A. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am. J. Hum. Genet. 2010, 87:560-566.
31. Jordanova A., Irobi J., Thomas F.P., Van Dijck P., Meerschaert K., Dewil M., Dierick I., Jacobs A., De Vriendt E., Guergueltcheva V., Rao C.V., Tournev I., Gondim F.A., D'Hooghe M., Van Gerwen V., Callaerts P., Van Den Bosch L., Timmermans J.P., Robberecht W., Gettemans J., Thevelein J.M., De Jonghe P., Kremensky I., Timmerman V. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat. Genet. 2006, 38:197-202.
32. Latour P., Thauvin-Robinet C., Baudelet-Mery C., Soichot P., Cusin V., Faivre L., Locatelli M.C., Mayencon M., Sarcey A., Broussolle E., Camu W., David A., Rousson R. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am. J. Hum. Genet. 2010, 86:77-82.
33. Vester A., Velez-Ruiz G., McLaughlin H.M., Nisc Comparative Sequencing P., Lupski J.R., Talbot K., Vance J.M., Zuchner S., Roda R.H., Fischbeck K.H., Biesecker L.G., Nicholson G., Beg A.A., Antonellis A. A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum. Mutat. 2013, 34:191-199.
34. Motley W.W., Seburn K.L., Nawaz M.H., Miers K.E., Cheng J., Antonellis A., Green E.D., Talbot K., Yang X.L., Fischbeck K.H., Burgess R.W. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet. 2011, 7:e1002399.
35. Achilli F., Bros-Facer V., Williams H.P., Banks G.T., AlQatari M., Chia R., Tucci V., Groves M., Nickols C.D., Seburn K.L., Kendall R., Cader M.Z., Talbot K., van Minnen J., Burgess R.W., Brandner S., Martin J.E., Koltzenburg M., Greensmith L., Nolan P.M., Fisher E.M. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis. Model. Mech. 2009, 2:359-373.
36. Guo M., Yang X.L., Schimmel P. New functions of aminoacyl-tRNA synthetases beyond translation. Nat. Rev. Mol. Cell Biol. 2010, 11:668-674.
37. Xu X., Shi Y., Zhang H.M., Swindell E.C., Marshall A.G., Guo M., Kishi S., Yang X.L. Unique domain appended to vertebrate tRNA synthetase is essential for vascular development. Nat. Commun. 2012, 3:681.
38. Kerjan P., Cerini C., Semeriva M., Mirande M. The multienzyme complex containing nine aminoacyl-tRNA synthetases is ubiquitous from Drosophila to mammals. Biochim. Biophys. Acta 1994, 1199:293-297.